Programme

Day 1 (5th of November 2026); 2.5h

TimeTopicSpeaker
Registration
17.00-17.15Introduction and welcomeRafa Fernández Chacón, Elisa Cordero, Olaf Neth
17.15-17.30
17.30-18.00Global impact of vaccines: progress, gaps and future prioritiesAndrew Pollard
18.00-18.30Paediatric CPE infections: Pitfalls and opportunities Pranita Tamma
18.30-19.00Sarcoidosis: Lessons from infection and immunitySteve Holland
19.00-20.00Interactive case discussions (n=3)Dana Danino/Simon Drysdale

Day 2 (6th of November 2026); 8.5h

TimeTopicSpeaker
9.00-9.30“To kiss or not to kiss”Nigel Curtis
9.30-10.00STIs: “back in force”Maria Espiau
10.00-10.30Congenital infections: an unfinished agenda Borja Guarch Ibáñez
10.30-11-30Interactive case discussions (n=3)Antoni Noguera/ Lola Falcon
11.30-12.00Coffee break
12.00-12.30When infection meets the brain: neuroinflammation in childhoodMichael Heneka
12.30-13.00Kawasaki disease “conundrums”Elisa Cooke
13.00-13.30Autoimmunity: insights from inborn errors of immunity and precision therapyPeter Olbrich
13.30-14.00Infections in the “immunocompromised”Dana Danino
14.00-15.00Lunch
15.00-15.30Neutrophils – orchestrators of immunitySteve Holland
15.30-16.00Beyond the infusion: post-CAR-T immune dynamicsCelia Marti
16.00-16.15Coffee break
16.15-17.00Antibiotic switch: things we do for no reasonBrad Spellberg
17.00-17.30IDSA vs ESCMID: P aeruginosa and difficult-to-treat resistance in childrenPranita Tamma
17.30-18.00Small patients, big challenges: Paediatric mycosesLaura Ferreras-Antolin
18.00-19.00Interactive case discussions (n=3)Celia Marti/ Walter Goycochea
19.00-19.15Closing remarksAll

Day 3 (7th of May 2026); 4.0h

TimeTopicSpeaker
9.00-09.30Diagnostic stewardshipWalter Goycochea
09.30-10.00Pharmacy: “Key player” in ASPConcepción Alvarez
10.00-10.30Beyond RSV: hMPV and “others”Simon Drysdale
10.30-11.00Coffee break
11.00-11.30Vaccines in paediatrics: good, great, or better than we think?Nigel Curtis
11.30-12.00From local to global: health and disease in perspectiveAndy Pollard
12.00-13.00Interactive case discussions (n=3)Peter Olbrich/Elisa Fernandez
13.00-13.30Evaluation/Discussions/Closing remarksAll